The french government has short listed two of the Midi-Pyrenees Region "Cancer Bio Sante" competitiveness cluster projects. Among them, the project "Research of a protein inhibitor for a lymphoma focused therapy" of which GTP is part. This projects links GTP Technology together with the French Pharma group "Pierre Fabre Laboratoires" and the academic INSERM 563 (Toulouse Purpan hospital) group.